Financial Architects, Inc Merck & Co., Inc. Call Options Transaction History

Financial Architects, Inc

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $20,952 - $24,477	-300 Reduced 42.86%	400 $34,000
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $333,984 - $380,928	-4,800 Reduced 87.27%	700 $58,000
Q3 2018 Oct 29, 2018	BUY	$57.69 - $67.84 $259,605 - $305,280	4,500 Added 450.0%	5,500 $390,000
Q1 2018 Apr 23, 2018	SELL	$50.96 - $59.23 $50,960 - $59,230	-1,000 Reduced 50.0%	1,000 $54,000
Q4 2017 Feb 12, 2018	BUY	$51.62 - $61.64 $103,240 - $123,280	2,000	2,000 $112,000

3,828

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $253B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.